21:41 The future in multiple myeloma: BiTE immunotherapy, CAR-T, and immune checkpoint inhibitors HMP Education
14:34 DEBATE: Which initial therapy for younger fit patients is best? - CyBord and BiRd HMP Education
14:15 DEBATE: One size fits all? Should everyone eligible get upfront autologous SCT - Pro HMP Education
11:56 DEBATE: One size fits all? Should everyone eligible get upfront autologous SCT - Con HMP Education
29:25 Keynote Lecture: Current Approach to the Treatment for the elderly myeloma patient HMP Education
